Drug
Darlifarnib
Darlifarnib: highest development phase Phase 1, developed by Mirati Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Mirati Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Darlifarnib NCT06026410 | Phase 1 | Solid Tumors With HRAS Alterations |
Latest
No recent events.
Follow Darlifarnib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.